Answer
Phesgo with docetaxel is indicated for adults with HER2-positive metastatic or locally recurrent unresectable breast cancer who have not received previous anti-HER2 therapy or chemotherapy for their metastatic disease.
Sources for this answer
- Phesgo 600 mg/600 mg, 1200 mg/600 mg solution for injectionRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked